Schlam I - Search Results

1

BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study.

Lynce F, Schlam I, Geng X, Peshkin BN, Friedman S, Dutil J, Nahleh Z, Campos C, Ricker C, Rodriguez P, Denduluri N, Ahn J, Isaacs C, Graves KD. Lynce F, et al. Among authors: schlam i. J Genet Couns. 2021 Apr;30(2):383-393. doi: 10.1002/jgc4.1322. Epub 2020 Oct 3. J Genet Couns. 2021. PMID: 33010199 Free PMC article.

2

Profile of Margetuximab: Evidence to Date in the Targeted Treatment of Metastatic HER2-positive Breast Cancer.

Schlam I, Nunes R, Lynce F. Schlam I, et al. Onco Targets Ther. 2022 Apr 28;15:471-478. doi: 10.2147/OTT.S272197. eCollection 2022. Onco Targets Ther. 2022. PMID: 35509453 Free PMC article. Review.

3

Emerging Targeted Therapies for Early Breast Cancer.

Schlam I, Tarantino P, Morganti S, Lynce F, Trapani D, Mayer EL, Garrido-Castro AC, Waks A, Tolaney SM. Schlam I, et al. Drugs. 2022 Sep;82(14):1437-1451. doi: 10.1007/s40265-022-01781-5. Epub 2022 Oct 7. Drugs. 2022. PMID: 36207645 Review.

4

The tumor immune microenvironment of primary and metastatic HER2- positive breast cancers utilizing gene expression and spatial proteomic profiling.

Schlam I, Church SE, Hether TD, Chaldekas K, Hudson BM, White AM, Maisonet E, Harris BT, Swain SM. Schlam I, et al. J Transl Med. 2021 Nov 27;19(1):480. doi: 10.1186/s12967-021-03113-9. J Transl Med. 2021. PMID: 34838031 Free PMC article.

5

Is there a role for CDK 4/6 inhibitors in breast cancer brain metastases?

Schlam I, Tolaney SM. Schlam I, et al. Oncotarget. 2021 Apr 27;12(9):873-875. doi: 10.18632/oncotarget.27904. eCollection 2021 Apr 27. Oncotarget. 2021. PMID: 33953840 Free PMC article. No abstract available.

6

Left Ventricular Assist Devices in Patients With Active Malignancies.

Schlam I, Lee AY, Li S, Sheikh FH, Zaghlol R, Basyal B, Gallagher C, Molina E, Mahr C, Cheng RK, Barac A. Schlam I, et al. JACC CardioOncol. 2021 Jun 15;3(2):305-315. doi: 10.1016/j.jaccao.2021.04.008. eCollection 2021 Jun. JACC CardioOncol. 2021. PMID: 34396339 Free PMC article.

7

Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx^® Digital Spatial Profiler.

Bergholtz H, Carter JM, Cesano A, Cheang MCU, Church SE, Divakar P, Fuhrman CA, Goel S, Gong J, Guerriero JL, Hoang ML, Hwang ES, Kuasne H, Lee J, Liang Y, Mittendorf EA, Perez J, Prat A, Pusztai L, Reeves JW, Riazalhosseini Y, Richer JK, Sahin Ö, Sato H, Schlam I, Sørlie T, Stover DG, Swain SM, Swarbrick A, Thompson EA, Tolaney SM, Warren SE, On Behalf Of The GeoMx Breast Cancer Consortium. Bergholtz H, et al. Among authors: schlam i. Cancers (Basel). 2021 Sep 4;13(17):4456. doi: 10.3390/cancers13174456. Cancers (Basel). 2021. PMID: 34503266 Free PMC article.

8

Overcoming Resistance to HER2-Directed Therapies in Breast Cancer.

Schlam I, Tarantino P, Tolaney SM. Schlam I, et al. Cancers (Basel). 2022 Aug 18;14(16):3996. doi: 10.3390/cancers14163996. Cancers (Basel). 2022. PMID: 36010990 Free PMC article. Review.

9

Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases.

Schlam I, Gatti-Mays ME. Schlam I, et al. Oncologist. 2022 Jul 5;27(7):538-547. doi: 10.1093/oncolo/oyac064. Oncologist. 2022. PMID: 35598254 Free PMC article. Review.

10

HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now.

Schlam I, Swain SM. Schlam I, et al. NPJ Breast Cancer. 2021 May 20;7(1):56. doi: 10.1038/s41523-021-00265-1. NPJ Breast Cancer. 2021. PMID: 34016991 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page